The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: Implications for clinical use
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: Implications for clinical use
Authors
Keywords
-
Journal
EPILEPSIA
Volume 53, Issue 3, Pages 425-436
Publisher
Wiley
Online
2012-01-06
DOI
10.1111/j.1528-1167.2011.03364.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Retigabine: the newer potential antiepileptic drug
- (2014) Piotr Czuczwar et al. Pharmacological Reports
- The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy
- (2012) Martin J. Gunthorpe et al. EPILEPSIA
- Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy
- (2011) J. A. French et al. NEUROLOGY
- Evaluation of development-specific targets for antiepileptogenic therapy using rapid kindling
- (2010) Raman Sankar et al. EPILEPSIA
- Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy
- (2010) M. J. Brodie et al. NEUROLOGY
- Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats
- (2009) Erwin A. van Vliet et al. EPILEPSIA
- Some correlations between the electroencephalogram and normal and pathologic mental processes
- (2009) John R. Hughes EPILEPSY & BEHAVIOR
- The relationship between sodium channel inhibition and anticonvulsant activity in a model of generalised seizure in the rat
- (2009) Charles H. Large et al. EPILEPSY RESEARCH
- Thalamo–cortical network pathology in idiopathic generalized epilepsy: Insights from MRI-based morphometric correlation analysis
- (2009) Boris C. Bernhardt et al. NEUROIMAGE
- Longitudinal and cross-sectional analysis of atrophy in pharmacoresistant temporal lobe epilepsy
- (2009) B. C. Bernhardt et al. NEUROLOGY
- Functional analysis of novel KCNQ2 mutations found in patients with Benign Familial Neonatal Convulsions
- (2009) Linda Volkers et al. NEUROSCIENCE LETTERS
- Genetics of complex neurological disease: challenges and opportunities for modeling epilepsy in mice and rats
- (2009) Wayne N. Frankel TRENDS IN GENETICS
- Antiepileptogenic and antiictogenic effects of retigabine under conditions of rapid kindling: An ontogenic study
- (2008) Andréy Mazarati et al. EPILEPSIA
- A new potential AED, carisbamate, substantially reduces spontaneous motor seizures in rats with kainate-induced epilepsy
- (2008) Heidi L. Grabenstatter et al. EPILEPSIA
- Development of tolerance to levetiracetam in rats with chronic epilepsy
- (2008) Erwin A. van Vliet et al. EPILEPSIA
- Molecular and cellular basis of epileptogenesis in symptomatic epilepsy
- (2008) Asla Pitkänen et al. EPILEPSY & BEHAVIOR
- Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (EILAT IX)
- (2008) Meir Bialer et al. EPILEPSY RESEARCH
- In Vivo Profile of ICA-27243 [N-(6-Chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a Potent and Selective KCNQ2/Q3 (Kv7.2/Kv7.3) Activator in Rodent Anticonvulsant Models
- (2008) R. Roeloffs et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Isobolographic characterization of interactions of retigabine with carbamazepine, lamotrigine, and valproate in the mouse maximal electroshock-induced seizure model
- (2008) Jarogniew J. Luszczki et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More